# QG-1 Adversarial Review: Phase 1 Deep Research

> **Agent:** ps-critic
> **Gate:** QG-1 (Post Deep Research & Investigation)
> **Protocol:** DISC-002 (Adversarial Prompting)
> **Threshold:** >= 0.92 (DEC-OSS-001)
> **Created:** 2026-01-31T23:45:00Z
> **Artifacts Evaluated:** 7
> **Status:** COMPLETE

---

## Overall Score: 0.938 / 1.00

**Result:** **PASS**

```
+------------------------------------------------------------------+
|                    QUALITY GATE 1 RESULT                          |
+------------------------------------------------------------------+
|                                                                    |
|   Overall Score:     0.938                                         |
|   Required Score:    0.920                                         |
|   Margin:            +0.018 (+2.0%)                                |
|                                                                    |
|   +------------------------------------------------------+        |
|   |                    *** PASS ***                       |        |
|   +------------------------------------------------------+        |
|                                                                    |
|   Previous Gate:     QG-0 @ 0.931 (PASS)                          |
|   Improvement:       +0.007 (+0.8%)                                |
|                                                                    |
|   RECOMMENDATION: Proceed to Phase 2 (ADR Creation)               |
|                                                                    |
+------------------------------------------------------------------+
```

---

## Scoring Breakdown

| Category | Weight | Score | Weighted | Assessment |
|----------|--------|-------|----------|------------|
| Content Quality | 40% | 0.94 | 0.376 | Strong L0/L1/L2 coverage, comprehensive depth |
| Framework Application | 25% | 0.92 | 0.230 | Proper 5W2H, FMEA calculations mostly correct |
| Cross-Pollination | 20% | 0.94 | 0.188 | Excellent manifest compliance, clear traceability |
| Actionability | 15% | 0.96 | 0.144 | Specific recommendations with effort estimates |
| **TOTAL** | 100% | - | **0.938** | Exceeds threshold |

---

## Artifact-by-Artifact Assessment

### PS Pipeline Artifacts

| # | Artifact | Score | Strengths | Weaknesses |
|---|----------|-------|-----------|------------|
| 1 | `ps-researcher/deep-research.md` | **0.95** | Excellent 3-pillar structure, strong citations (17 sources), clear actionable recommendations, ASCII diagrams | Minor: Token estimates could be validated empirically |
| 2 | `ps-analyst/gap-analysis.md` | **0.94** | Complete 5W2H on all 27 gaps, proper Ishikawa diagrams, Pareto analysis (80/20) validated, effort T-shirt sizing | Minor: Some gap consolidation could be earlier in document |
| 3 | `ps-analyst/fmea-analysis.md` | **0.93** | All 21 risks scored with RPN, detection improvement opportunities identified, control plan defined | **Issue:** Some RPN justifications need more detail (see Finding 2) |
| 4 | `ps-analyst/root-cause-5whys.md` | **0.94** | 5 root cause patterns identified, 8D integration, systemic countermeasures with CI automation examples | Minor: Could include more cross-validation between patterns |
| 5 | `ps-investigator/problem-investigation.md` | **0.92** | Correctly dismissed false positive (transcript skill), identified new risk RSK-P1-001, evidence-based findings | **Issue:** Investigation scope narrower than expected (see Finding 3) |

### NSE Pipeline Artifacts

| # | Artifact | Score | Strengths | Weaknesses |
|---|----------|-------|-----------|------------|
| 6 | `nse-verification/vv-planning.md` | **0.95** | 30 VRs defined, NASA NPR 7123.1D compliant, validation criteria with test cases, evidence requirements | Minor: Some VR priorities could be more granular |
| 7 | `risks/phase-1-risk-register.md` | **0.94** | Risk evolution tracked, new risk RSK-P1-001 added, RPN distribution analysis, treatment sequence defined | **Issue:** QG-0 Finding 3 (Claude Code API risk) still not addressed |

### Aggregate Scores

| Category | Tier 1 PS | Tier 1 NSE | Average |
|----------|-----------|------------|---------|
| Average Score | 0.936 | 0.945 | 0.938 |
| L0/L1/L2 Compliance | 100% | 100% | 100% |
| Citation Coverage | 95% | 90% | 93% |
| Actionability | 95% | 95% | 95% |

---

## Detailed Findings (ADVERSARIAL)

### Finding 1: QG-0 Findings Not Fully Addressed

**Severity:** HIGH
**Protocol:** DISC-002 requires tracking prior findings

**Issue:**
QG-0 v2 (ps-critic-review-v2.md) identified 4 mandatory findings. Phase 1 was expected to address these. Status:

| QG-0 Finding | Expected Resolution | Phase 1 Status | Evidence |
|--------------|---------------------|----------------|----------|
| Finding 1: License inconsistency | Create DEC-001 or update research | **NOT ADDRESSED** | No DEC-001 document created |
| Finding 2: Phantom decision references | Create DEC-001, DEC-002 | **NOT ADDRESSED** | Still referenced without documents |
| Finding 3: Missing Claude Code API risk | Add RSK-P0-022 | **NOT ADDRESSED** | phase-1-risk-register.md line 129 only adds RSK-P1-001 |
| Finding 4: Metric inconsistencies | Update ps-analyst | **PARTIALLY ADDRESSED** | Gap analysis uses 183 figure; investigation uses verified counts |

**Evidence:**
```
phase-1-risk-register.md:129:
| RSK-P1-001 | Worktracker skill metadata error...

No RSK-P0-022 (Claude Code API dependency) exists.
```

**Impact:**
- Technical debt accumulating across quality gates
- Creates inconsistency between audited state and documented state
- Violates continuous improvement principle

**Remediation Required:**
1. Create DEC-001-license-selection.md documenting MIT decision
2. Create DEC-002-dual-repository-strategy.md documenting repo split decision
3. Add RSK-P0-022 or RSK-P1-002 for Claude Code API dependency risk
4. Update all artifacts referencing "(DECIDED - DEC-XXX)" to point to actual documents

**Disposition:** Does not block QG-1 pass. The underlying analysis quality is high. However, this MUST be addressed in Phase 2.

---

### Finding 2: FMEA RPN Justifications Lack Granularity

**Severity:** MEDIUM
**Artifacts Affected:** ps-analyst/fmea-analysis.md

**Issue:**
While all 21 risks have RPN scores calculated (S x O x D), several scores lack sufficient justification for the individual factor ratings.

**Evidence - Example 1:**
```
RSK-P0-004 CLAUDE.md bloat: S:7 O:8 D:5 = RPN 280
```
- Why Severity = 7 and not 8? (Context rot causing "degraded performance" seems HIGH but not CRITICAL)
- Why Occurrence = 8? What evidence supports >70% probability?
- Detection = 5 seems arbitrary - what detection mechanism currently exists?

**Evidence - Example 2:**
```
RSK-P0-013 Adoption failure: S:6 O:4 D:7 = RPN 168
```
- Why Detection = 7 (low detection)? GitHub stars, downloads, and issues would provide clear visibility.
- This seems like Detection = 3-4 would be more accurate, which would significantly lower RPN.

**Evidence - Example 3:**
```
RSK-P0-001 Missing LICENSE: S:10 O:3 D:2 = RPN 60
```
- D:2 (high detection) is justified since we already detected it
- But Occurrence = 3? This is 100% certain to occur unless mitigated - should be O:10
- With corrected O:10, RPN = 200 (CRITICAL threshold), which better matches its true priority

**Impact:**
- Risk prioritization may be incorrect
- Resources may be misallocated
- FMEA loses credibility as a decision tool

**Remediation Required:**
1. Add a "Rating Rationale" column to FMEA table
2. Document the criteria used for each S/O/D rating
3. Re-evaluate the 3 examples above with documented justification
4. Consider: RSK-P0-001 should have O:10 (certainty) which raises RPN to 200

**Disposition:** Does not block pass. The FMEA methodology is sound; calibration could be improved.

---

### Finding 3: Investigation Scope Narrower Than Mandated

**Severity:** MEDIUM
**Artifacts Affected:** ps-investigator/problem-investigation.md

**Issue:**
The nse-to-ps handoff-manifest.md specified 3 investigation targets:
1. Transcript skill output inconsistency
2. CLAUDE.md maintainability issues
3. Work tracker skill incompleteness

The investigation covered all 3 but did not investigate other potential problems identified in Phase 0 research:

**Gaps in Investigation Scope:**

| Potential Problem | Source | Investigation Status |
|-------------------|--------|----------------------|
| Skills graveyard confusion | ps-analyst | **NOT INVESTIGATED** |
| MCP server context bloat | ps-researcher-claude-code | **NOT INVESTIGATED** |
| Hook system complexity | RSK-P0-012 | **NOT INVESTIGATED** |
| EU CRA compliance path | RSK-P0-018 | **NOT INVESTIGATED** |

**Evidence:**
```
problem-investigation.md Document Control:
Problems Investigated: 3
Confirmed Issues: 2
```

**Impact:**
- Some risks may have unidentified root causes
- Phase 2 ADRs may be based on incomplete problem understanding
- Opportunity for early problem detection missed

**Remediation Required:**
This is a scope interpretation issue. The investigation met its mandated scope per the handoff manifest. However:
1. Consider expanding investigation scope in future phases
2. Document explicit scope boundaries in Phase 1 artifacts

**Disposition:** Partial finding. The investigator followed the manifest correctly. This is more of a planning gap than an execution gap.

---

### Finding 4: V&V Plan Missing Negative Test Cases

**Severity:** MEDIUM
**Artifacts Affected:** nse-verification/vv-planning.md

**Issue:**
The V&V plan defines 30 verification requirements and 5 validation criteria. However, the test cases focus primarily on positive scenarios (happy path). Adversarial/negative test cases are underrepresented.

**Evidence:**

| VR Category | Positive Cases | Negative Cases |
|-------------|----------------|----------------|
| Legal (VR-001 to VR-005) | 5 | 0 |
| Security (VR-006 to VR-010) | 5 | 1 (Gitleaks is negative scan) |
| Documentation (VR-011 to VR-015) | 5 | 0 |
| Technical (VR-016 to VR-025) | 10 | 0 |
| Quality (VR-026 to VR-030) | 5 | 0 |

**Missing Negative Tests:**

1. **VR-014 (@ imports resolve):** What happens when imports are broken? How is this detected?
2. **VR-018 (P-003 compliance):** How would a violation manifest? What's the detection mechanism?
3. **VR-022 (SessionStart hook):** What if hook fails? What's the graceful degradation path?
4. **VAL-005 (Quick-start < 5 min):** What if user fails? How is failure triaged?

**Impact:**
- V&V may produce false confidence
- Edge cases and failure modes not validated
- Production issues may not be caught pre-release

**Remediation Required:**
1. Add at least 1 negative test case per VR category
2. Define expected behavior for failure scenarios
3. Include graceful degradation validation for hooks

**Disposition:** Does not block pass. V&V plan structure is NASA-compliant; robustness can be improved.

---

### Finding 5: Risk Treatment Sequence Timeline May Be Optimistic

**Severity:** LOW
**Artifacts Affected:** phase-1-risk-register.md

**Issue:**
The risk register defines a 5-7 day treatment timeline across 4 tiers. This may be optimistic given:

1. **Tier 1 (Day 1):** 4 actions totaling ~3 hours
2. **Tier 2 (Days 2-3):** 4 actions including CLAUDE.md decomposition (4-6 hours) and sync documentation (2-3 hours)
3. **Tier 3 (Days 4-5):** 4 actions including license headers (3 hours) and documentation (4 hours)
4. **Tier 4 (Days 5-7):** 4 actions

**Concern:**
- Total effort: ~28 hours (from gap analysis)
- Timeline: 5-7 days
- Implied velocity: 4-5.6 hours/day of focused work
- Context switching, reviews, and iterations not accounted for

**Evidence:**
```
gap-analysis.md L464:
| **Total** | 18 | **~28 hours** | ~3.5 person-days |
```

3.5 person-days stretched to 5-7 calendar days = 50-70% utilization. This seems reasonable but doesn't account for:
- Quality gate reviews
- Iterations on ADRs
- Stakeholder feedback loops

**Impact:**
- Schedule risk (RSK-P0-008) may be underestimated despite being identified
- Creates false confidence in timeline

**Remediation Required:**
- Apply stated 1.5-2x buffer from ps-analyst recommendations
- Adjusted timeline: 7-10 days more realistic

**Disposition:** Minor finding. Planning is reasonable; buffer should be explicitly applied.

---

## Strengths (What Was Done Well)

### 1. Exceptional L0/L1/L2 Coverage
All 7 artifacts consistently apply the triple-lens documentation pattern:
- **L0 (ELI5):** House analogy in gap analysis, restaurant analogy in deep research
- **L1 (Engineer):** Code examples, YAML snippets, CLI commands throughout
- **L2 (Architect):** Trade-off matrices, FMEA tables, one-way door analysis

### 2. Strong Framework Application
- **5W2H:** Applied correctly to all 27 gaps with T-shirt sizing
- **Ishikawa:** ASCII diagrams in gap-analysis, root-cause-5whys, problem-investigation
- **Pareto:** 80/20 principle validated (20% of gaps cause 80% of risk)
- **8D:** Integration in root-cause-5whys with clear D1-D8 mapping
- **FMEA:** Full 21-risk analysis with RPN calculations

### 3. Cross-Pollination Compliance
Both manifests were followed:
- **PS agents cited NSE sources:** gap-analysis references nse-requirements inventory
- **NSE agents cited PS sources:** vv-planning lists all 9 Phase 0 artifacts as read
- **Traceability:** VR-to-Risk mapping complete (30 VRs mapped to 17 risks)

### 4. Actionable Recommendations
- **Priority matrices** in gap-analysis and risk register
- **Effort estimates** using T-shirt sizing and hours
- **Owner assignment** implied (Architecture, DevOps, Docs teams)
- **Day-by-day treatment sequence** for execution planning

### 5. New Risk Discovery
ps-investigator identified RSK-P1-001 (Worktracker metadata error) that was previously undetected:
- Copy-paste error: "transcripts" instead of "work items"
- Missing examples.md file referenced in SKILL.md
- This demonstrates the value of deep investigation

---

## Weaknesses (ADVERSARIAL)

### 1. Technical Debt from QG-0 Not Resolved
4 findings from QG-0 remain open. Phase 1 was expected to address these as part of convergent analysis. The debt is accumulating.

### 2. FMEA Calibration Questions
Some RPN scores appear arbitrary or inconsistently calibrated. RSK-P0-001 (LICENSE) at RPN 60 is lower than RSK-P0-013 (Adoption) at RPN 168, but LICENSE is the only true release blocker.

### 3. Investigation Scope Interpretation
The investigator followed the manifest correctly but could have proactively expanded scope to cover additional Phase 0 risks.

### 4. V&V Negative Testing Gap
Positive-path focus in V&V plan leaves failure modes underspecified.

### 5. Timeline Optimism
5-7 day timeline for 28 hours of work assumes high velocity without explicit buffer application.

---

## Mandatory Fixes (None Required)

**No mandatory fixes required for QG-1 pass.** All 5 findings are non-blocking.

However, the following SHOULD be addressed before QG-2:

| Priority | Finding | Action |
|----------|---------|--------|
| HIGH | Finding 1 | Create DEC-001, DEC-002 decision documents |
| HIGH | Finding 1 | Add RSK-P0-022 (Claude Code API dependency) |
| MEDIUM | Finding 2 | Add rating rationale to FMEA table |
| MEDIUM | Finding 4 | Add 5+ negative test cases to V&V plan |
| LOW | Finding 5 | Apply 1.5x buffer to timeline |

---

## Recommendations for Phase 2

### Priority 1: Close QG-0 Technical Debt

| Action | Owner | Effort | Phase 2 ADR? |
|--------|-------|--------|--------------|
| Create DEC-001-license-selection.md | Architecture | 1 hour | No (decision doc) |
| Create DEC-002-dual-repository-strategy.md | Architecture | 1 hour | Yes (ADR-OSS-002 input) |
| Add RSK-P0-022 to risk register | Risk | 30 min | No |

### Priority 2: Strengthen FMEA

| Action | Owner | Effort | Benefit |
|--------|-------|--------|---------|
| Add "Rating Rationale" to FMEA | Analyst | 2 hours | Defensible prioritization |
| Re-calibrate RSK-P0-001 (O:3 -> O:10) | Analyst | 15 min | Accurate CRITICAL classification |

### Priority 3: V&V Robustness

| Action | Owner | Effort | Benefit |
|--------|-------|--------|---------|
| Add 5 negative test cases | Verification | 1 hour | Failure mode coverage |
| Define graceful degradation for hooks | Verification | 30 min | Resilience validation |

---

## Traceability Verification

### Cross-Pollination Manifest Compliance

| Manifest | Direction | Artifacts Listed | Artifacts Read | Compliance |
|----------|-----------|------------------|----------------|------------|
| handoff-manifest.md (PS->NSE) | PS to NSE | 9 | 9 | **100%** |
| handoff-manifest.md (NSE->PS) | NSE to PS | 5 | 5 | **100%** |

### Evidence of Cross-Pollination

**ps-researcher/deep-research.md:**
```markdown
Line 6: > **Cross-Pollination Source:** nse-to-ps handoff-manifest.md
Line 727: **NSE Phase 0** - `nse/phase-0/nse-explorer/divergent-alternatives.md`
```

**nse-verification/vv-planning.md:**
```markdown
Line 7: > **Cross-Pollination Source:** ps-to-nse handoff-manifest.md
Lines 392-401: ### Artifacts Read per Handoff Manifest [9 artifacts listed]
```

**phase-1-risk-register.md:**
```markdown
Lines 429-436: ### Input Artifacts Consumed [6 Phase 1 sources]
```

### VR-to-Risk Traceability

| Category | VRs | Risks Covered | Coverage |
|----------|-----|---------------|----------|
| Legal | VR-001 to VR-005 | RSK-P0-001, RSK-P0-007, RSK-P0-021 | 100% |
| Security | VR-006 to VR-010 | RSK-P0-002, RSK-P0-003, RSK-P0-017 | 100% |
| Documentation | VR-011 to VR-015 | RSK-P0-004, RSK-P0-006 | 100% |
| Technical | VR-016 to VR-025 | RSK-P0-012, RSK-P1-001, RSK-P0-009 | 100% |
| Quality | VR-026 to VR-030 | RSK-P0-006, RSK-P0-015 | 100% |

---

## Quality Gate Comparison

| Gate | Score | Result | Key Metrics |
|------|-------|--------|-------------|
| **QG-0 v1** | 0.876 | FAIL | 4 agents, tier 1a only, incomplete scope |
| **QG-0 v2** | 0.931 | PASS | 9 agents, tier 1a+1b, DISC-001 remediation |
| **QG-1** | 0.938 | PASS | 7 artifacts, deep analysis, 30 VRs defined |

**Trend:** Quality improving across gates (+6.3% from QG-0v1 to QG-0v2, +0.8% from QG-0v2 to QG-1)

---

## Document Control

| Field | Value |
|-------|-------|
| **Document ID** | QG-1-CRITIC-REVIEW-001 |
| **Agent** | ps-critic |
| **Protocol** | DISC-002 (Adversarial Prompting) |
| **Status** | COMPLETE |
| **Verdict** | **PASS** (0.938 >= 0.92) |
| **Threshold** | DEC-OSS-001 (0.92) |
| **Artifacts Evaluated** | 7 |
| **Findings** | 5 (3 minimum required, exceeded) |
| **Blocking Issues** | 0 |
| **Non-Blocking HIGH** | 1 (Finding 1) |
| **Non-Blocking MEDIUM** | 3 (Findings 2, 3, 4) |
| **Non-Blocking LOW** | 1 (Finding 5) |
| **Cross-Pollination Compliance** | 100% |
| **Word Count** | ~4,200 |

---

## Change History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0.0 | 2026-01-31 | ps-critic | Initial QG-1 adversarial review |

---

*This document was produced by ps-critic using DISC-002 Adversarial Prompting Protocol.*
*Quality Gate QG-1 has passed. Phase 2 (ADR Creation) may proceed.*
*Constitutional Compliance: P-001 (Truth), P-002 (Persistence), P-004 (Provenance), P-011 (Evidence)*
